» Articles » PMID: 37770710

A New Bayesian Factor Analysis Method Improves Detection of Genes and Biological Processes Affected by Perturbations in Single-cell CRISPR Screening

Overview
Journal Nat Methods
Date 2023 Sep 28
PMID 37770710
Authors
Affiliations
Soon will be listed here.
Abstract

Clustered regularly interspaced short palindromic repeats (CRISPR) screening coupled with single-cell RNA sequencing has emerged as a powerful tool to characterize the effects of genetic perturbations on the whole transcriptome at a single-cell level. However, due to its sparsity and complex structure, analysis of single-cell CRISPR screening data is challenging. In particular, standard differential expression analysis methods are often underpowered to detect genes affected by CRISPR perturbations. We developed a statistical method for such data, called guided sparse factor analysis (GSFA). GSFA infers latent factors that represent coregulated genes or gene modules; by borrowing information from these factors, it infers the effects of genetic perturbations on individual genes. We demonstrated through extensive simulation studies that GSFA detects perturbation effects with much higher power than state-of-the-art methods. Using single-cell CRISPR data from human CD8 T cells and neural progenitor cells, we showed that GSFA identified biologically relevant gene modules and specific genes affected by CRISPR perturbations, many of which were missed by existing methods, providing new insights into the functions of genes involved in T cell activation and neurodevelopment.

Citing Articles

Decoding heterogeneous single-cell perturbation responses.

Song B, Liu D, Dai W, McMyn N, Wang Q, Yang D Nat Cell Biol. 2025; 27(3):493-504.

PMID: 40011559 PMC: 11906366. DOI: 10.1038/s41556-025-01626-9.


Modeling and predicting single-cell multi-gene perturbation responses with scLAMBDA.

Wang G, Liu T, Zhao J, Cheng Y, Zhao H bioRxiv. 2024; .

PMID: 39677694 PMC: 11643044. DOI: 10.1101/2024.12.04.626878.


High-throughput screening for optimizing adoptive T cell therapies.

Zhang Y, Xu Q, Gao Z, Zhang H, Xie X, Li M Exp Hematol Oncol. 2024; 13(1):113.

PMID: 39538305 PMC: 11562648. DOI: 10.1186/s40164-024-00580-w.


A scalable, high-throughput neural development platform identifies shared impact of ASD genes on cell fate and differentiation.

Wang X, Lalli M, Thopte U, Buxbaum J bioRxiv. 2024; .

PMID: 39386704 PMC: 11463611. DOI: 10.1101/2024.09.25.614184.


Guide assignment in single-cell CRISPR screens using crispat.

Braunger J, Velten B Bioinformatics. 2024; 40(9).

PMID: 39240651 PMC: 11399228. DOI: 10.1093/bioinformatics/btae535.


References
1.
Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna J, Charpentier E . A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 2012; 337(6096):816-21. PMC: 6286148. DOI: 10.1126/science.1225829. View

2.
Wang H, La Russa M, Qi L . CRISPR/Cas9 in Genome Editing and Beyond. Annu Rev Biochem. 2016; 85:227-64. DOI: 10.1146/annurev-biochem-060815-014607. View

3.
Shalem O, Sanjana N, Hartenian E, Shi X, Scott D, Mikkelson T . Genome-scale CRISPR-Cas9 knockout screening in human cells. Science. 2013; 343(6166):84-87. PMC: 4089965. DOI: 10.1126/science.1247005. View

4.
Buquicchio F, Satpathy A . Interrogating immune cells and cancer with CRISPR-Cas9. Trends Immunol. 2021; 42(5):432-446. PMC: 9345562. DOI: 10.1016/j.it.2021.03.003. View

5.
Weber J, Braun C, Saur D, Rad R . In vivo functional screening for systems-level integrative cancer genomics. Nat Rev Cancer. 2020; 20(10):573-593. DOI: 10.1038/s41568-020-0275-9. View